Demant A/S (0RGT)
London Exchange · UK · prices in DKK · close of 23 Oct 2026
Key indicators
| Last close | DKK 360.70 |
|---|---|
| 52-week range | 175.00 – 363.70 |
| Return, 1 month / 3 months | +17.1% / +33.7% |
| Return, 1 year / 3 years | +53.5% / +39.4% |
| Trend | Uptrend |
| RSI (14) | 74 |
| Volatility (1 year) | 33.5% |
| Worst drawdown (1 year) | -25.1% |
| Average daily value traded | 14.65M DKK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Demant A/S is a hearing healthcare company based in Denmark. It develops and makes hearing aids, which it offers under several brand names, and it also supplies audiology equipment used to test and fit hearing instruments. Alongside manufacturing, the company operates hearing care clinics and retail outlets where people can be assessed and fitted with hearing solutions. Its customers include hearing care professionals, clinics and the people who use its hearing devices across many countries.
The shares are listed on the London Exchange in UK under the code 0RGT, and the price on this page is in Danish kroner (DKK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Demant A/S (0RGT) trades on the London Exchange in UK. It last closed at DKK 360.70 on 23 October 2026.
Its price-based Market X-Ray is 80 out of 100 (a strong price profile), ranking 65 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 53.5% and over the last three months it rose 33.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 95 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 44.4% | ||
| From 52-week high | -0.8% | ||
| Momentum | 89 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 33.7% | ||
| 6-month return | 73.9% | ||
| 12-month return, skipping the last month | 31.0% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.1% | ||
| Liquidity | 77 · Strong | Trades actively. | |
| Average daily value traded | 14.65M DKK | ||
| Zero-volume days | 6.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.0% |
|---|---|
| 1 month | +17.1% |
| 3 months | +33.7% |
| 6 months | +73.9% |
| 1 year | +53.5% |
| 3 years | +39.4% |
| 5 years | +17.5% |
Signals
| 50-day / 200-day average | 312.00 / 249.83 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 6.27 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.